Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell”

6,284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,284 results

Early research (Phase 1)Not Yet RecruitingNCT04595162
What this trial is testing

GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Peking University Third Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Not applicableActive Not RecruitingNCT06731179
What this trial is testing

A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay

Who this might be right for
Long COVIDPTLDsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
ViraxBio Labs 160
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Not applicableStudy completedNCT04998331
What this trial is testing

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, Cutaneous
Takeda 51
Early research (Phase 1)Not Yet RecruitingNCT07211737
What this trial is testing

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+1 more
Baylor College of Medicine 27
Not applicableStudy completedNCT00738569
What this trial is testing

Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen

Who this might be right for
HIV
National Jewish Health 30
Testing effectiveness (Phase 2)Study completedNCT01193283
What this trial is testing

Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaNeutropeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 22
Testing effectiveness (Phase 2)Study completedNCT00042822
What this trial is testing

FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03630731
What this trial is testing

Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 32
Not applicableWithdrawnNCT00951795
What this trial is testing

Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts

Who this might be right for
HIV InfectionAIDSHIV Infections
Abbott RDx Cardiometabolic
Very early researchStudy completedNCT01722149
What this trial is testing

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University of Zurich 4
Testing effectiveness (Phase 2)Study completedNCT00036738
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Blastic Phase+7 more
Fred Hutchinson Cancer Center 28
Not applicableStudy completedNCT02779049
What this trial is testing

Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease

Who this might be right for
Mycobacterium Avium
National Taiwan University Hospital 112
Early research (Phase 1)WithdrawnNCT02059850
What this trial is testing

NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Who this might be right for
Adult Synovial SarcomaMyxoid/Round Cell LiposarcomaRecurrent Adult Soft Tissue Sarcoma+2 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00961220
What this trial is testing

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Who this might be right for
Recurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaStage I Mycosis Fungoides and Sezary Syndrome AJCC v7Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7
National Cancer Institute (NCI) 17
Early research (Phase 1)Ended earlyNCT04401410
What this trial is testing

Anti-SARS Cov-2 T Cell Infusions for COVID 19

Who this might be right for
SARS-CoV 2Viral InfectionCOVID 19
Baylor College of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12
Not applicableUnknownNCT00343369
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Universitätsklinikum Hamburg-Eppendorf 550
Early research (Phase 1)Looking for participantsNCT07413341
What this trial is testing

A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's Syndrome (SS)Systemic Sclerosis (SSc)+2 more
Therorna 12
Load More Results